PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Medicine, Trinity Translational Medicine Institute, School of Medicine, Trinity College Dublin, D08 W9RT Dublin, Ireland.\', \'Department of Immunology, St. James\'s Hospital, D08 NHY1 Dublin, Ireland.\', \'Department of Immunology, School of Medicine, Trinity College Dublin, D02 R590 Dublin, Ireland.\', \'Department of Infectious Diseases, St James\'s Hospital, D08 NHY1 Dublin, Ireland.\', \'Peak Proteins Ltd., Alderley Park, Mereside, Macclesfield SK10 4TG, UK.\', \'Department of Microbiology, Icahn School of Medicine, Mount Sinai, New York, NY 10029-5674, USA.\', \'Trinity Health Kidney Centre, Trinity Translational Medicine Institute, Trinity College Dublin, St. James\' Hospital Campus, D08 W9RT Dublin, Ireland.\', \'Department of Pharmacy, St James\'s Hospital, D08 NHY1 Dublin, Ireland.\']
?:citedBy
  • -1
?:creator
?:doi
  • 137110.3390/v13071371
?:doi
?:hasPublicationType
?:journal
  • Viruses
is ?:pmid of
?:pmid
?:pmid
  • 34372581
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.805
?:rankingScore_hIndex
  • 52
?:title
  • Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all